DBPR112
DBPR112 is an orally active furanopyrimidine-based EGFR inhibitor with IC50s of 15 nM for EGFRWT and 48 nM for EGFRL858R/T790M, capable of occupying the ATP-binding site and demonstrating significant antitumor efficacy.
Product Specifications
CAS Number
1226549-49-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
533.62
Molecular Formula
C32H31N5O3
Notes
Research use only, not for human use.
Receptor
EGFR
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL308163V 500 µL Each
ZNF510 Human shRNA Lentiviral Particle (Locus ID 22869)
Sign In for Pricing
View Details 
MBS1305269 Inquire
Recombinant Clostridium perfringens ATP synthase subunit alpha (atpA), partial
Sign In for Pricing
View Details